These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 12239328)
1. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. Allen TM; Jing P; Calore B; Horton H; O'Connor DH; Hanke T; Piekarczyk M; Ruddersdorf R; Mothé BR; Emerson C; Wilson N; Lifson JD; Belyakov IM; Berzofsky JA; Wang C; Allison DB; Montefiori DC; Desrosiers RC; Wolinsky S; Kunstman KJ; Altman JD; Sette A; McMichael AJ; Watkins DI J Virol; 2002 Oct; 76(20):10507-11. PubMed ID: 12239328 [TBL] [Abstract][Full Text] [Related]
2. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723 [TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques. Nakamura M; Takahara Y; Ishii H; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T; Matsuoka S Microbiol Immunol; 2011 Nov; 55(11):768-73. PubMed ID: 21895748 [TBL] [Abstract][Full Text] [Related]
4. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques. Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066 [TBL] [Abstract][Full Text] [Related]
5. A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02. Newberg MH; Kuroda MJ; Charini WA; Miura A; Lord CI; Schmitz JE; Gorgone DA; Lifton MA; Kuus-Reichel K; Letvin NL Virology; 2002 Sep; 301(2):365-73. PubMed ID: 12359438 [TBL] [Abstract][Full Text] [Related]
6. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I. Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704 [TBL] [Abstract][Full Text] [Related]
7. Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys. Santra S; Schmitz JE; Kuroda MJ; Lifton MA; Nickerson CE; Lord CI; Pal R; Franchini G; Letvin NL J Immunol; 2002 Feb; 168(4):1847-53. PubMed ID: 11823518 [TBL] [Abstract][Full Text] [Related]
8. Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences. Moriya C; Igarashi H; Takeda A; Tsukamoto T; Kawada M; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Nagai Y; Matano T Microbes Infect; 2008 Mar; 10(3):285-92. PubMed ID: 18316225 [TBL] [Abstract][Full Text] [Related]
9. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977 [TBL] [Abstract][Full Text] [Related]
10. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. Mothé BR; Horton H; Carter DK; Allen TM; Liebl ME; Skinner P; Vogel TU; Fuenger S; Vielhuber K; Rehrauer W; Wilson N; Franchini G; Altman JD; Haase A; Picker LJ; Allison DB; Watkins DI J Virol; 2002 Jan; 76(2):875-84. PubMed ID: 11752176 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lord CI; Forman MA; Letvin NL J Virol; 1999 Feb; 73(2):1573-9. PubMed ID: 9882363 [TBL] [Abstract][Full Text] [Related]
12. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202 [TBL] [Abstract][Full Text] [Related]
13. Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques. Ishii H; Kawada M; Tsukamoto T; Yamamoto H; Matsuoka S; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Naruse TK; Kimura A; Takiguchi M; Matano T J Virol; 2012 Jan; 86(2):738-45. PubMed ID: 22072784 [TBL] [Abstract][Full Text] [Related]
14. Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection. Kaur A; Yang J; Hempel D; Gritz L; Mazzara GP; McClure H; Johnson RP J Immunol; 2000 Jan; 164(2):934-43. PubMed ID: 10623842 [TBL] [Abstract][Full Text] [Related]
15. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694 [TBL] [Abstract][Full Text] [Related]
16. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. Kawada M; Tsukamoto T; Yamamoto H; Iwamoto N; Kurihara K; Takeda A; Moriya C; Takeuchi H; Akari H; Matano T J Virol; 2008 Oct; 82(20):10199-206. PubMed ID: 18667518 [TBL] [Abstract][Full Text] [Related]
17. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope. Sharpe SA; Cope A; Dowall S; Berry N; Ham C; Heeney JL; Hopkins D; Easterbrook L; Dennis M; Almond N; Cranage M J Gen Virol; 2004 Sep; 85(Pt 9):2591-2602. PubMed ID: 15302953 [TBL] [Abstract][Full Text] [Related]
18. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques. Tsukamoto T; Takeda A; Yamamoto T; Yamamoto H; Kawada M; Matano T J Virol; 2009 Sep; 83(18):9339-46. PubMed ID: 19587045 [TBL] [Abstract][Full Text] [Related]
19. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge. Yasutomi Y; Koenig S; Woods RM; Madsen J; Wassef NM; Alving CR; Klein HJ; Nolan TE; Boots LJ; Kessler JA J Virol; 1995 Apr; 69(4):2279-84. PubMed ID: 7884874 [TBL] [Abstract][Full Text] [Related]
20. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys. Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]